SCHEMBL3437188

SCHEMBL3437188

C=C(C#N)C=Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.48
▸ LMNA P02545 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ HDAC3 O15379 2/20 0.48
▸ HDAC4 P56524 2/20 0.48
▸ HDAC1 Q13547 2/20 0.48
▸ HDAC2 Q92769 2/20 0.48
▸ HDAC8 Q9BY41 2/20 0.48
▸ HDAC6 Q9UBN7 2/20 0.48
▸ PLIN1 O60240 2/20 0.48
▸ RECQL P46063 2/20 0.48
▸ PLIN5 Q00G26 2/20 0.48
▸ ABHD5 Q8WTS1 2/20 0.48
▸ F3 P13726 2/20 0.48
▸ TNKS O95271 1/20 0.48
▸ HCAR2 Q8TDS4 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48
▸ HDAC11 Q96DB2 1/20 0.48
▸ TNKS2 Q9H2K2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3951014 1.00 MAPT (0.48) MAPTLMNAALDH1A1HDAC3HDAC4
Acrylonitrile SCHEMBL29191949 0.93 KDM4E (0.44) MAPTLMNAALDH1A1HDAC3HDAC4
SCHEMBL25633237 0.80 MAPT (0.47) MAPTALDH1A1CYP2C9SMN1; SMN2MAOB
SCHEMBL6688122 0.79 MAPT (0.54) MAPTLMNAALDH1A1HDAC3HDAC4
SCHEMBL7935925 0.79 MAPT (0.54) MAPTLMNAALDH1A1HDAC3HDAC4
(Z)-1,2-Diphenylethene SCHEMBL4447909 0.78 MCL1 (0.44) MAPTLMNAALDH1A1HDAC3HDAC4
SCHEMBL21758829 0.76 LMNA (0.42) MAPTLMNAALDH1A1HDAC3HDAC4
Styrene SCHEMBL27564913 0.76 ALDH1A1 (0.48) MAPTALDH1A1HDAC8SMN1; SMN2TDP1
Styrene SCHEMBL10775344 0.76 ALDH1A1 (0.48) MAPTLMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL551223 0.76 MAPT (0.54) MAPTLMNAALDH1A1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1343892-A Polarization optical combiner and polariscope YAMAMOTO OPTICAL CO LTD (JP) 2002-04-10 — — CN claimed
CN-112533751-B Attaching an object to a substrate 多种材料焊接股份公司 2023-06-16 — — CN disclosed
CN-101542368-B Liquid crystal panel and liquid crystal display device NITTO DENKO CORP 2011-09-14 — — CN disclosed
US-20100331549-A1 Novel compounds useful for modulating abnormal cell proliferation ROIFMAN CHAIM 2010-12-30 — — US disclosed
US-7807719-B2 Compounds useful for modulating abnormal cell proliferation Roifman, Chaim (CA) 2010-10-05 — — US disclosed
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 — — US disclosed
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 — — US disclosed
CN-101500540-A Nanoparticulate kinase inhibitor formulations ELAN PHARMA INT LTD (IE) 2009-08-05 — — CN disclosed
EP-1797064-A4 NOVEL COMPOUNDS USEFUL FOR MODULATING ABNORMAL CELL PROLIFERATION HOSPITAL FOR SICK CHILDREN (CA) 2009-06-24 — — EP disclosed
EP-2043606-A2 NANOPARTICULATE KINASE INHIBITOR FORMULATIONS Elan Pharma International Limited (IE) 2009-04-08 — — EP disclosed
EP-1272457-A2 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2003-01-08 — — EP disclosed
EP-1272457-A2 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2003-01-08 — — EP disclosed
CN-1343892-A Polarization optical combiner and polariscope YAMAMOTO OPTICAL CO LTD (JP) 2002-04-10 — — CN disclosed
WO-2001079158-A3 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2002-01-31 — — WO disclosed
WO-2001079158-A2 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2001-10-25 — — WO disclosed
WO-2001079158-A2 COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2001-10-25 — — WO disclosed
EP-0594056-B1 Thermoplastic moulding composition BASF AG (DE) 1998-04-15 — — EP disclosed
EP-0594056-A1 Thermoplastic moulding composition BASF Aktiengesellschaft (DE) 1994-04-27 — — EP disclosed
US-4112021-A SUSPENSION POLYMERIZATION SUMITOMO NAUGATUCK CO., LTD. (JP) 1978-09-05 — — US disclosed
US-3943161-A Process for producing conjugated dienes containing a cyano group TOYO SODA MANUFACTURING CO., LTD. (JA) 1976-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331549-A1 Novel compounds useful for modulating abnormal cell proliferation MKI67, CALU, CDK4 MAPT 2662/4885LMNA 2586/4885ALDH1A1 1908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback